Used as a chiral building block in the synthesis of pharmaceutical compounds, particularly in the development of protease inhibitors and other biologically active molecules. Its structure contains both a fluorenylmethyloxycarbonyl (Fmoc) protecting group and a chlorine-substituted aromatic ring, making it valuable in solid-phase peptide synthesis and medicinal chemistry. The compound enables stereoselective synthesis due to its defined chirality, enhancing the efficacy and specificity of the target drug molecules. It is also employed in research settings for the preparation of enzyme inhibitors and receptor ligands where precise spatial arrangement of functional groups is critical.